Compare CTKB & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | KREF |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.1M | 561.2M |
| IPO Year | 2021 | 2017 |
| Metric | CTKB | KREF |
|---|---|---|
| Price | $5.04 | $8.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $5.88 | ★ $10.71 |
| AVG Volume (30 Days) | ★ 1.2M | 914.6K |
| Earning Date | 11-05-2025 | 02-02-2026 |
| Dividend Yield | N/A | ★ 11.74% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $196,828,000.00 | $62,012,000.00 |
| Revenue This Year | N/A | $16.86 |
| Revenue Next Year | $5.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.37 | $7.78 |
| 52 Week High | $7.30 | $11.53 |
| Indicator | CTKB | KREF |
|---|---|---|
| Relative Strength Index (RSI) | 53.03 | 48.58 |
| Support Level | $4.71 | $8.42 |
| Resistance Level | $5.13 | $8.63 |
| Average True Range (ATR) | 0.20 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 79.20 | 10.14 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.